Found 469 results in Expert Content

Summary: A key hurdle for any drug development program is bringing the drug to clinical studies. Astute companies strategize past this milestone and plan for clinical and regulatory success.

Summary: ​Patient-focused drug design can be a key factor in real-world therapeutic outcomes and business success. But if successful treatments should be created with patients in mind...

Summary: ​Patient centricity has always been at the heart of the pharmaceutical industry. With rising costs of drugs and healthcare, there has been an increased focus on the topic. Poor patient acceptance and...

Summary: The use of spray drying to manufacture amorphous dispersions is continuing to grow due to the number of drug candidates exhibiting poor solubility.

Summary: The influx of poorly soluble compounds into the drug development pipeline is likely to continue unabated. Solid dispersions provide a formulation technique that is...

Summary: Our regulatory team completes over 150 agency submissions each year, supporting all stages of the product lifecycle. We assign a dedicated...

Summary: Catalyst + Talent. Our name combines these ideas. From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your...

Summary: Softgel technology is the commercially-proven choice for encapsulation of challenging compounds. In addition, softgel technology may enhance the bioavailability of your product to...

Summary: Softgel technology offers a number of technical benefits. Probably foremost is the improvement or enhanced bioavailability that's often achievable with the Softgel dosage...

Summary: Catalent is much more than just a vendor or a supplier. What we're trying to provide is a true strategic partnership, to become an extension, if you like, of their organization, and that can...